Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jiangxi University Of Chinese Medicine is active in the Biotechnology & Pharmaceuticals technology area. The university currently has 1 pending office action. This matter is assigned to 1 distinct examiner and 1 distinct art unit. Ganapathy Krishnan is the busiest examiner, managing the 1 pending office action.
The university's prosecution is highly focused, with only 1 pending office action currently active. Ganapathy Krishnan is the sole examiner reviewing the university's biotechnology filings. The 1 distinct art unit provides the specific technical context for this examination.
Practitioners should focus their strategy on the requirements of Ganapathy Krishnan and the standards of the 1 distinct art unit to advance this single pending matter. This 1 pending office action represents the university's entire active portfolio in the Biotechnology & Pharmaceuticals field. Success depends on a deep understanding of the technical standards within the 1 distinct art unit as applied by Ganapathy Krishnan.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRISHNAN, GANAPATHY | 1 | 52.7% | +1.3% |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18575307 | SLOWLY-DIGESTED PUERARIA MONTANA VAR. THOMSONII STARCH AND PREPARATION METHOD THEREOF | KRISHNAN, GANAPATHY | 1693 | §103 | Non-Final OA | — | Pending | Dec 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJiangxi University Of Chinese Medicine has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ganapathy Krishnan has the most, with 1 of Jiangxi University Of Chinese Medicine's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
